Replies to post #5263 on InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[236T568]

yes, that is probably what the market is reacting negatively to

Yeah disappointing to hear that there is no progress with patient 2, 4, 5. I think this is also what the market thinks. But I am still impressed with the scoence behind and will buy the dips for sure.

[nsomniyak]

That is the biggest challenge with NVIV - the sample size is so small that the results are by nature very "lumpy" and not statistically significant. The nature of the treatment is that there are not that many subjects, and the individual experience of each gets unduly weighted.